Andersen Christopher R, Presseau Justin, Saigle Victoria, Fitzgerald Emily, Lamanna Madeline, Talbot Phil, Delaney Anthony, English Shane W
Northern Clinical School, Sydney University, Sydney, NSW, Australia.
The George Institute for Global Health, UNSW, Newtown, NSW, Australia.
Front Neurol. 2022 Nov 25;13:1068499. doi: 10.3389/fneur.2022.1068499. eCollection 2022.
To understand which outcome measures patients and their families, health care providers, and researchers prioritize after aneurysmal subarachnoid hemorrhage (aSAH).
We conducted a cross-sectional q-sort survey with participants from three key stakeholder groups. Potential outcomes were identified from interviews and focus groups. Participants were purposively sampled to achieve diversity based on stakeholder group, geography, and profession. Respondents sorted 27 outcomes in a quasi-normally distributed grid (Q-Sort) from most to least important. Principal components analysis was used to determine similarities in the way participants sorted the outcome measures resulting in distinct groupings. Overall rankings were also reported.
112 participants were invited. 70 responded and 64 participants from 25 different countries completed a Q-sort. Balanced stakeholder representation was achieved. Five distinct patterns were identified based on survival, pathophysiological, psychological, resource use, and functional outcome measures. Quality of life as reported by the patient was the highest ranked outcome measure followed by independence and functional measures. Survival and biomedical outcomes were ranked in the middle and cost measures last.
In this diverse sample of key stakeholders, we characterized several distinct perspectives with respect to outcome measure selection in aSAH. We did not identify a clear pattern of opinion based on stakeholder group or other participant characteristics. Patient-reported measure of quality of life was ranked the most important overall with function and independence also highly rated. These results will assist study design and inform efforts to improve outcome selection in aSAH research.
了解动脉瘤性蛛网膜下腔出血(aSAH)后患者及其家属、医疗保健提供者和研究人员优先考虑的结局指标。
我们对来自三个关键利益相关者群体的参与者进行了横断面Q分类调查。通过访谈和焦点小组确定潜在结局。基于利益相关者群体、地理位置和职业,有目的地对参与者进行抽样以实现多样性。受访者将27项结局指标在一个近似正态分布的网格(Q分类)中从最重要到最不重要进行排序。主成分分析用于确定参与者对结局指标进行排序方式的相似性,从而得出不同的分组。还报告了总体排名。
邀请了112名参与者。70人做出回应,来自25个不同国家的64名参与者完成了Q分类。实现了利益相关者的均衡代表性。基于生存、病理生理、心理、资源利用和功能结局指标确定了五种不同模式。患者报告的生活质量是排名最高的结局指标,其次是独立性和功能指标。生存和生物医学结局指标排名居中,成本指标排名最后。
在这个由关键利益相关者组成的多样化样本中,我们描述了在aSAH结局指标选择方面的几种不同观点。我们没有根据利益相关者群体或其他参与者特征确定明确的意见模式。患者报告的生活质量指标总体上被评为最重要,功能和独立性也得到高度评价。这些结果将有助于研究设计,并为改善aSAH研究中的结局选择提供参考。